ArticleGeroScience2026
Impact of miR-181a-5p and miR-1249-3p treatment on the visceral adipose tissue transcriptome of female mice.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
MicroRNAs (miRNAs) regulate gene expression and can influence processes such as inflammation, metabolism, and aging. This study assessed the effects of miR-181a-5p and miR-1249-3p mimics on the transcriptome of visceral adipose tissue in middle-aged females mice. Mice received intraperitoneal injections of either miR-181a-5p, miR-1249-3p, or vehicle control, followed by transcriptomic and metabolic analyses. Both treatments significantly reduced fasting blood glucose levels and promoted overexpression of the respective miRNAs in adipose tissue. RNA-Seq analysis revealed that both miRNAs modulated genes involved in immune regulation, energy metabolism, and insulin signaling. miR-181a-5p predominantly upregulated immune and inflammatory pathways such as Jak-STAT and Toll-like receptor signaling, whereas miR-1249-3p downregulated metabolic pathways related to lipid oxidation and oxidative phosphorylation. Despite opposing effects, both miRNAs induced gene-expression profiles resembling those observed in long-lived, growth hormone-deficient mice, suggesting a shared role in promoting insulin sensitivity and metabolic resilience. These findings highlight miR-181a-5p and miR-1249-3p as potential therapeutic targets for improving metabolic health and delaying age-related dysfunctions in adipose tissue.
Indexed as
Identifiers
41952006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.